NASDAQ: CRDL · Drug Manufacturers - Specialty & Generic
Over the past week, Cardiol Therapeutics (CRDL) logged 5 mentions across Reddit, X and news, and the read is an Adanos Hold. That is too little tracked discussion to read a direction from, so the signal stays neutral. Wall Street is more constructive, with 5 of 5 analysts rating CRDL a buy.
Tracked discussion on CRDL is too thin this week to read a direction from, which is why it reads as a Hold.
Wall Street’s 100% buy share sits next to a crowd that ranges from News at 50% to Reddit at 100%. No other tracker puts the two side by side.
5 analysts have weighed in: a Strong Buy consensus: 5 buy calls against 0 sell, with an average 12-month price target of $7.44.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week CRDL carries too few tracked mentions to weigh any of them, so the read is Hold rather than a clear buy or sell.
Analysts sit 33 points above the crowd average of 67%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 100% bullish while News sits at 50%, a 50-point spread that single-source trackers miss.
Over the 30-day window, Cardiol Therapeutics (CRDL) buzz held subdued around 31.9 while the price drifted up 30.4% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.1M shares. Updated Aug 12, 2026. Over the last 7 trading days, CRDL gained 14.5%. Buzz activity in the recent week averaged 24.9 and was relatively stable, swinging between 16.6 and 31.9. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 3 of the 7 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for CRDL and 1160+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live CRDL sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 12, 2026.
Adanos will not call Cardiol Therapeutics (CRDL) either way right now. The last 7 days carry 5 tracked mentions across 3 sources, under the 10-mention floor, so the signal sits at a neutral hold with 40/100 conviction. This is a sentiment-based reading, not financial advice.
Reddit discussion around Cardiol Therapeutics (CRDL) is fairly quiet with 1 mentions over the last 7 days; the 30-day context spans 2 tracked subreddits. The 7-day tone is 100% bullish; 3-day activity momentum is stable, suggesting steady attention.
There is not enough tracked discussion on Cardiol Therapeutics (CRDL) to call it either way. The last 7 days carry 5 tracked mentions across 3 sources, under the 10-mention floor Adanos needs before it reads a direction. On the professional side, 5 of 5 analysts rate CRDL a buy.
Of the 5 analysts covering Cardiol Therapeutics (CRDL), 5 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $7.44. That puts the street ahead of the crowd, which averages 67% bullish.
Cardiol Therapeutics (CRDL) does not carry enough tracked discussion this week to have a readable sentiment. 5 mentions across 3 sources is under the 10-mention floor, so the signal stays neutral at 40/100 conviction.
Not for a reason found in the sentiment itself. Cardiol Therapeutics (CRDL) drew 5 tracked mentions in the last 7 days, too small a sample to read a direction from, so Adanos holds the signal neutral instead of calling a buy or sell off it.
X is the dominant discussion channel with 2 mentions (40% of total volume). News contributes 2 mentions and Reddit contributes 1 mention. There is too little of it to read a sentiment direction from.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. CRDL's hold signal at 40/100 conviction reflects a sample too thin to read a direction from. It is a research shortcut, not financial advice.
The CRDL sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to Cardiol Therapeutics with similar bullish ratios, signal direction and discussion volume. All 6 peers carry hold signals, pointing to broad mixed pressure rather than an CRDL-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key